OpenFilings

Lyell Immunopharma, Inc.

Form8-K/A

Report Period2024-10-31

Date Filed2025-01-10

Time Filed09:10:41

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

8-K/A
EX-23.1
EX-99.1
EX-99.2
EX-99.3
Filing on SEC Edgar